Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases

DOPA decarboxylase, the dimeric enzyme responsible for the synthesis of neurotransmitters dopamine and serotonin, is involved in severe neurological diseases such as Parkinson disease, schizophrenia, and depression. Binding of the pyridoxal-5′-phosphate (PLP) cofactor to the apoenzyme is thought to represent a central mechanism for the regulation of its activity. We solved the structure of the human apoenzyme and found it exists in an unexpected open conformation: compared to the pig kidney holoenzyme, the dimer subunits move 20 Å apart and the two active sites become solvent exposed. Moreover, by tuning the PLP concentration in the crystals, we obtained two more structures with different conformations of the active site. Analysis of three-dimensional data coupled to a kinetic study allows to identify the structural determinants of the open/close conformational change occurring upon PLP binding and thereby propose a model for the preferential degradation of the apoenzymes of Group II decarboxylases.

[1]  P. Clayton,et al.  Pyridoxal 5′‐phosphate deficiency causes a loss of aromatic l‐amino acid decarboxylase in patients and human neuroblastoma cells, implications for aromatic l‐amino acid decarboxylase and vitamin B6 deficiency states , 2010, Journal of neurochemistry.

[2]  V. Malashkevich,et al.  Structural insight into Parkinson's disease treatment from drug-inhibited DOPA decarboxylase , 2001, Nature Structural Biology.

[3]  M. Rowley,et al.  Molecular characterization of a disease associated conformational epitope on GAD65 recognised by a human monoclonal antibody b96.11. , 2007, Molecular immunology.

[4]  Alexei Vagin,et al.  Molecular replacement with MOLREP. , 2010, Acta crystallographica. Section D, Biological crystallography.

[5]  Akiyoshi Nishimura,et al.  Aromatic l-amino acid decarboxylase-immunoreactive structures in human midbrain, pons, and medulla , 2009, Journal of Chemical Neuroanatomy.

[6]  A. Børglum,et al.  Aromatic l-amino acid decarboxylase expression profiling and isoform detection in the developing porcine brain , 2010, Brain Research.

[7]  Mengsu Yang,et al.  Interaction between pyridoxal kinase and pyridoxal-5-phosphate-dependent enzymes. , 2003, Journal of biochemistry.

[8]  A. Bellelli,et al.  The mechanism of addition of pyridoxal 5'-phosphate to Escherichia coli apo-serine hydroxymethyltransferase. , 2007, The Biochemical journal.

[9]  M. Rowley,et al.  A diabetes-related epitope of GAD65: a major diabetes-related conformational epitope on GAD65. , 2003, Annals of the New York Academy of Sciences.

[10]  G. Rajkowska,et al.  Reduced level of glutamic acid decarboxylase-67 kDa in the prefrontal cortex in major depression. , 2010, The international journal of neuropsychopharmacology.

[11]  S. Hori,et al.  Effect of pyridoxal phosphate deficiency on aromatic L-amino acid decarboxylase activity with L-DOPA and L-5-hydroxytryptophan as substrates in rats. , 1982, Japanese journal of pharmacology.

[12]  Judy H. Cho,et al.  L-histidine decarboxylase and Tourette's syndrome. , 2010, The New England journal of medicine.

[13]  Jack Snoeyink,et al.  Nucleic Acids Research Advance Access published April 22, 2007 MolProbity: all-atom contacts and structure validation for proteins and nucleic acids , 2007 .

[14]  A. Scorilas,et al.  Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma , 2010, British Journal of Cancer.

[15]  P. Moore,et al.  Cloning and expression of pig kidney dopa decarboxylase: comparison of the naturally occurring and recombinant enzymes. , 1996, The Biochemical journal.

[16]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[17]  T. Guilarte,et al.  Effects of Perinatal Vitamin B6 Deficiency on Dopaminergic Neurochemistry , 1987, Journal of neurochemistry.

[18]  S. Heales,et al.  A new perspective on the treatment of aromatic L-amino acid decarboxylase deficiency. , 2009, Molecular genetics and metabolism.

[19]  Vinod Subramaniam,et al.  Local changes in the catalytic site of mammalian histidine decarboxylase can affect its global conformation and stability. , 2003, European journal of biochemistry.

[20]  M. Bertoldi,et al.  Mutation of Tyrosine 332 to Phenylalanine Converts Dopa Decarboxylase into a Decarboxylation-dependent Oxidative Deaminase* , 2002, The Journal of Biological Chemistry.

[21]  C. H. Chen,et al.  Structural characteristics of brain glutamate decarboxylase in relation to its interaction and activation. , 1998, Archives of biochemistry and biophysics.

[22]  G. Schneider,et al.  The manifold of vitamin B6 dependent enzymes. , 2000, Structure.

[23]  P. Christen,et al.  Multiple evolutionary origin of pyridoxal-5'-phosphate-dependent amino acid decarboxylases. , 1994, European journal of biochemistry.

[24]  J. Whisstock,et al.  GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop , 2007, Nature Structural &Molecular Biology.

[25]  Richard H. Myers,et al.  Decreased glutamic acid decarboxylase mRNA expression in prefrontal cortex in Parkinson's disease , 2010, Experimental Neurology.

[26]  M. Safo,et al.  Vitamin B(6) salvage enzymes: mechanism, structure and regulation. , 2011, Biochimica et biophysica acta.

[27]  R. Montioli,et al.  Molecular insights into the pathogenicity of variants associated with the aromatic amino acid decarboxylase deficiency , 2011, Journal of Inherited Metabolic Disease.

[28]  Ming-hui Li,et al.  Crystal Structure of Brain Pyridoxal Kinase, a Novel Member of the Ribokinase Superfamily* , 2002, The Journal of Biological Chemistry.

[29]  M. Bertoldi,et al.  Mutation of cysteine 111 in Dopa decarboxylase leads to active site perturbation , 1997, Protein science : a publication of the Protein Society.

[30]  T. Stadtman,et al.  Vitamin B12 , 1971, Science.

[31]  M. Rowley,et al.  A Diabetes‐Related Epitope of GAD65 , 2003 .

[32]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[33]  H. Hayashi,et al.  Instability of the apo form of aromatic L-amino acid decarboxylase in vivo and in vitro: implications for the involvement of the flexible loop that covers the active site. , 2004, Journal of biochemistry.

[34]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[35]  K. Dakshinamurti,et al.  Effect of pyridoxine deficiency on aromatic L-amino acid decarboxylase in adult rat brain , 2004, Experimental Brain Research.

[36]  O. Abdel-Salam.  Drugs used to treat Parkinson's disease, present status and future directions. , 2008, CNS & neurological disorders drug targets.

[37]  D. Larsen,et al.  Rapid photodynamics of vitamin B6 coenzyme pyridoxal 5'-phosphate and its Schiff bases in solution. , 2008, The journal of physical chemistry. B.

[38]  Miguel Angel Medina,et al.  Mammalian histidine decarboxylase: from structure to function , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[39]  P. Clayton.  B6-responsive disorders: A model of vitamin dependency , 2006, Journal of Inherited Metabolic Disease.

[40]  M. Toney,et al.  pH studies on the mechanism of the pyridoxal phosphate-dependent dialkylglycine decarboxylase. , 1999, Biochemistry.

[41]  F. Kwok,et al.  Interactions of pyridoxal kinase and aspartate aminotransferase emission anisotropy and compartmentation studies. , 1988, The Journal of biological chemistry.